☆ 4.7 Article

Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes Pros and cons

DIABETES CARE (2011)

Get Full Text
Add to Collection

Journal

DIABETES CARE
Volume 34, Issue -, Pages S197-S201

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc11-s219

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. AstraZeneca
  2. Boehringer Ingelheim
  3. Bristol-Myers Squibb
  4. Daiichi Sankyo
  5. Eli Lilly
  6. Ethicon Endo-Surgery
  7. Generex Biotechnology
  8. F. Hoffmann-La Roche
  9. Janssen-Cilag
  10. Johnson Johnson
  11. Novo Nordisk
  12. Medtronic
  13. Pfizer
  14. Abbott Diabetes Care
  15. Dexcom

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.